Search
for
Sort by
Research 601–630 of 1000+
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population
- Congenital adrenal hyperplasia
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Exosomes as a novel pathway for regulating development and diseases of the skin (Review)
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Obsessive-compulsive disorder in dermatology
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women
- A Technique for Reconstruction of Eyebrows and Eyelashes
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Cutaneous Blood Flow.
- Alopecia and Hirsuties
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Oral medications for central serous chorioretinopathy: a literature review
- Promoting axonal regeneration through exosomes: An update of recent findings on exosomal PTEN and mTOR modifiers
- Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Nonsurgical Therapy for Hair Loss
- Antiandrogen therapy for androgenetic alopecia
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Localisation and regulation of cholesterol transporters in the human hair follicle: mapping changes across the hair cycle
- Morpho‐regulation in diverse chicken feather formation: Integrating branching modules and sex hormone‐dependent morpho‐regulatory modules